What are the CDC guidelines on HIV screening in men who have sex with men (MSM)?

Updated: Jul 27, 2020
  • Author: Shelley A Gilroy, MD, FACP, FIDSA; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print

The following are guidelines on HIV screening among men who have sex with men (MSM) [158]

  • The CDC concludes that the evidence, programmatic experience, and expert opinions are insufficient to warrant changing the current recommendation of annual screening for men who have sex with men (MSM) to more frequent screening (every 3 or 6 months).
  • Providers in clinical settings should offer HIV screening at least annually to all sexually active MSM.
  • Clinicians can also consider the potential benefits of more frequent HIV screening (eg, every 3 or 6 months) for some asymptomatic sexually active MSM based on their individual risk factors, local HIV epidemiology, and local policies.
  • Among MSM who are prescribed preexposure prophylaxis, HIV testing every 3 months and immediate testing whenever signs and symptoms of acute HIV infection are reported is indicated.
  • MSM who experience a specific high-risk sexual exposure or have symptoms of recent HIV infection should seek immediate HIV testing, and clinicians should be alert for the symptoms of acute HIV infection and provide appropriate diagnostic testing.
  • Tenofovir alafenamide (TAF)/emtricitabine (FTC) is now included as an alternative for pre-exposure prophylaxis (PrEP) in men who have sex with men (MSM).

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!